Find uplifting stories about heroes, innovations, and solutions
26 results for "schizophrenia"
Researchers discovered over 100 new genes linked to schizophrenia by studying African ancestry populations for the first time. The breakthrough could help doctors spot warning signs earlier and develop better treatments.
A groundbreaking Chinese study involving 1,200 people has discovered concrete connections between gut bacteria and psychiatric disorders, potentially revolutionizing how doctors diagnose and treat conditions like depression and schizophrenia. The research reveals that changes in gut microbiome directly correlate with symptom severity and cognitive performance.
A groundbreaking opera premiering at UCLA tells the true story of renowned legal scholar Elyn Saks, who built a celebrated career while living with schizophrenia. The free performances celebrate resilience and challenge stigma around serious mental illness.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
Scientists are using tiny lab-grown brain models called organoids to solve mysteries about how our incredible brains develop. These breakthrough tools could lead to new treatments for autism, schizophrenia, and other brain conditions.
Scientists at MIT identified a gene mutation that causes the brain to get stuck on outdated beliefs and successfully reversed the effect in mice. The discovery opens promising new treatment paths for cognitive symptoms in schizophrenia patients.
A simple retinal scan can now reveal signs of mental health conditions like schizophrenia and bipolar disorder, thanks to an AI-powered kiosk bringing breakthrough diagnostics to underserved communities in India. The technology offers hope for millions who lack access to psychiatric care.
Groundbreaking conversations are changing how families support loved ones with schizophrenia, one of the most misunderstood mental health conditions. Advocates say simple connection—sharing meals, showing up, listening without judgment—makes all the difference.
Northwestern University researchers discovered a biomarker that could finally treat the cognitive symptoms of schizophrenia that current medications miss. A synthetic protein tested in animal models successfully reversed brain abnormalities linked to memory and thinking problems.
Scientists at Northwestern University discovered a biomarker that could lead to the first effective treatment for cognitive symptoms of schizophrenia, potentially helping millions live independently. A single injection improved brain function in early tests with no negative side effects.
A single family just crossed $1 billion in donations to mental health research, with their latest $280 million gift funding breakthroughs in bipolar disorder and schizophrenia. The timing couldn't be better as federal research funding faces uncertainty.
Researchers created Hektor, a tickle robot that's helping solve age-old questions about why humans are ticklish and what it reveals about our brains. The playful experiments could lead to breakthroughs in understanding autism, schizophrenia, and how we process touch.
After losing her mother and brother for 10 years to untreated schizophrenia, Neha Kirpal co-founded Amaha to transform mental healthcare access across India. Her childhood survival became millions of people's lifeline to support.
The FDA just approved a new treatment option for people living with bipolar 1 disorder and schizophrenia. Bysanti offers fresh hope for millions managing these challenging mental health conditions.
UCSF researchers are using brain scans to identify who will develop schizophrenia years before psychosis starts, potentially preventing the disease entirely. Early detection could transform treatment for the 1% of people worldwide affected by this condition.
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.
The FDA just approved BYSANTI, a new medication offering hope to millions of Americans living with schizophrenia and bipolar I disorder. Built on more than a decade of proven safety data, this treatment represents a faster path to innovation in mental health care.
Researchers in Israel used deep-brain stimulation to dramatically reduce hallucinations in patients with treatment-resistant schizophrenia, opening a new frontier for the 30% who don't respond to medication. One patient said the voices that controlled his life finally became quiet.
Scientists in Israel successfully reversed schizophrenia symptoms in lab trials using targeted brain stimulation, offering hope for millions who don't respond to current treatments. The breakthrough could transform care for one-third of the world's 21 million schizophrenia patients.
Three mothers whose sons developed schizophrenia are fighting to change a broken mental health system. Their advocacy is creating real solutions for families navigating one of healthcare's toughest challenges.
Showing 20 of 26